Insider Selling: Surgery Partners, Inc. (NASDAQ:SGRY) CFO Sells $349,346.01 in Stock

Surgery Partners, Inc. (NASDAQ:SGRY) CFO David T. Doherty sold 13,641 shares of the company’s stock in a transaction on Friday, February 7th. The stock was sold at an average price of $25.61, for a total value of $349,346.01. Following the sale, the chief financial officer now owns 108,862 shares of the company’s stock, valued at approximately $2,787,955.82. This represents a 11.14 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Surgery Partners Stock Performance

Shares of SGRY stock opened at $25.35 on Thursday. The firm has a market capitalization of $3.22 billion, a price-to-earnings ratio of -52.81, a price-to-earnings-growth ratio of 17.77 and a beta of 2.60. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.80 and a quick ratio of 1.66. The business has a fifty day moving average of $21.99 and a 200 day moving average of $26.84. Surgery Partners, Inc. has a 1 year low of $19.50 and a 1 year high of $35.29.

Surgery Partners (NASDAQ:SGRY) last issued its earnings results on Tuesday, November 12th. The company reported $0.19 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.06). The firm had revenue of $770.40 million during the quarter, compared to analysts’ expectations of $768.99 million. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The business’s revenue was up 14.3% on a year-over-year basis. During the same quarter last year, the business earned $0.15 EPS. As a group, research analysts expect that Surgery Partners, Inc. will post 0.71 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on SGRY. JPMorgan Chase & Co. lowered their target price on Surgery Partners from $38.00 to $28.00 and set a “neutral” rating for the company in a report on Tuesday, December 3rd. Royal Bank of Canada decreased their price objective on Surgery Partners from $49.00 to $35.00 and set an “outperform” rating for the company in a report on Wednesday, November 20th. Macquarie reiterated an “outperform” rating and set a $34.00 price objective on shares of Surgery Partners in a report on Tuesday, November 19th. Finally, Bank of America started coverage on Surgery Partners in a report on Monday, December 16th. They set a “buy” rating and a $30.00 price objective for the company. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $36.56.

Hedge Funds Weigh In On Surgery Partners

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in SGRY. Handelsbanken Fonder AB raised its stake in Surgery Partners by 35.1% in the 3rd quarter. Handelsbanken Fonder AB now owns 18,100 shares of the company’s stock worth $584,000 after acquiring an additional 4,700 shares during the last quarter. Creative Planning acquired a new stake in Surgery Partners during the 3rd quarter worth about $258,000. E. Ohman J or Asset Management AB grew its position in Surgery Partners by 31.0% during the 3rd quarter. E. Ohman J or Asset Management AB now owns 886,088 shares of the company’s stock worth $28,567,000 after purchasing an additional 209,888 shares during the period. Smith Group Asset Management LLC grew its position in Surgery Partners by 48.6% during the 3rd quarter. Smith Group Asset Management LLC now owns 16,160 shares of the company’s stock worth $521,000 after purchasing an additional 5,282 shares during the period. Finally, Harbor Capital Advisors Inc. grew its position in Surgery Partners by 16.0% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 53,855 shares of the company’s stock worth $1,736,000 after purchasing an additional 7,441 shares during the period.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.